Literature DB >> 18950705

Fibroblast growth factor inhibits interferon gamma-STAT1 and interleukin 6-STAT3 signaling in chondrocytes.

Pavel Krejci1, Jirina Prochazkova, Vitezslav Bryja, Petra Jelinkova, Katerina Pejchalova, Alois Kozubik, Leslie Michels Thompson, William R Wilcox.   

Abstract

Activation of fibroblast growth factor receptor 3 (FGFR3) leads to attenuation of cartilage growth. The members of the STAT family of transcription factors are believed to participate in FGFR3 signaling in cartilage, however the molecular mechanism of this action is poorly understood. Here, we demonstrate that a chronic FGF stimulus leads to accumulation of STAT1, 3, 5 and 6, evident in both in vitro chondrocyte model and murine limb explant cultures. Despite the accumulation, both endogenous and cytokine-induced activation of STAT1 and STAT3 is impaired by FGF, as demonstrated by imaging of active STAT nuclear translocation and analyses of STAT activatory phosphorylation and transcriptional activation. Further, we demonstrate that FGF induces expression of CIS, SOCS1 and SOCS3 inhibitors of gp130, a common receptor for the IL6-family of cytokines. Since cytokine-gp130 signaling represents an important positive regulator of cartilage, its inhibition may contribute to the growth-inhibitory effect of FGFR3 in cartilage.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18950705      PMCID: PMC2655766          DOI: 10.1016/j.cellsig.2008.10.006

Source DB:  PubMed          Journal:  Cell Signal        ISSN: 0898-6568            Impact factor:   4.315


  29 in total

1.  Gly369Cys mutation in mouse FGFR3 causes achondroplasia by affecting both chondrogenesis and osteogenesis.

Authors:  L Chen; R Adar; X Yang; E O Monsonego; C Li; P V Hauschka; A Yayon; C X Deng
Journal:  J Clin Invest       Date:  1999-12       Impact factor: 14.808

2.  Molecular dynamics of STAT3 on IL-6 signaling pathway in living cells.

Authors:  Kenji Watanabe; Kenta Saito; Masataka Kinjo; Tadashi Matsuda; Mamoru Tamura; Shigeyuki Kon; Tadaaki Miyazaki; Toshimitsu Uede
Journal:  Biochem Biophys Res Commun       Date:  2004-11-26       Impact factor: 3.575

3.  Fibroblast growth factor inhibits chondrocytic growth through induction of p21 and subsequent inactivation of cyclin E-Cdk2.

Authors:  T Aikawa; G V Segre; K Lee
Journal:  J Biol Chem       Date:  2001-05-30       Impact factor: 5.157

4.  Activation of the ERK1/2 and p38 mitogen-activated protein kinase pathways mediates fibroblast growth factor-induced growth arrest of chondrocytes.

Authors:  Angela Raucci; Emmanuel Laplantine; Alka Mansukhani; Claudio Basilico
Journal:  J Biol Chem       Date:  2003-10-30       Impact factor: 5.157

5.  FGF2 inhibits proliferation and alters the cartilage-like phenotype of RCS cells.

Authors:  Pavel Krejci; Vitezslav Bryja; Jiri Pachernik; Ales Hampl; Robert Pogue; Pertchoui Mekikian; William R Wilcox
Journal:  Exp Cell Res       Date:  2004-07-01       Impact factor: 3.905

6.  Glycoprotein 130 regulates bone turnover and bone size by distinct downstream signaling pathways.

Authors:  Natalie A Sims; Brendan J Jenkins; Julian M W Quinn; Akira Nakamura; Markus Glatt; Matthew T Gillespie; Matthias Ernst; T John Martin
Journal:  J Clin Invest       Date:  2004-02       Impact factor: 14.808

7.  Overexpression of FGFR3, Stat1, Stat5 and p21Cip1 correlates with phenotypic severity and defective chondrocyte differentiation in FGFR3-related chondrodysplasias.

Authors:  L Legeai-Mallet; C Benoist-Lasselin; A Munnich; J Bonaventure
Journal:  Bone       Date:  2004-01       Impact factor: 4.398

8.  Null leukemia inhibitory factor receptor (LIFR) mutations in Stuve-Wiedemann/Schwartz-Jampel type 2 syndrome.

Authors:  Nathalie Dagoneau; Deborah Scheffer; Céline Huber; Lihadh I Al-Gazali; Maja Di Rocco; Anne Godard; Jelena Martinovic; Annick Raas-Rothschild; Sabine Sigaudy; Sheila Unger; Sophie Nicole; Bertrand Fontaine; Jean-Luc Taupin; Jean-François Moreau; Andrea Superti-Furga; Martine Le Merrer; Jacky Bonaventure; Arnold Munnich; Laurence Legeai-Mallet; Valérie Cormier-Daire
Journal:  Am J Hum Genet       Date:  2004-01-21       Impact factor: 11.025

9.  Cell growth arrest and induction of cyclin-dependent kinase inhibitor p21 WAF1/CIP1 mediated by STAT1.

Authors:  Y E Chin; M Kitagawa; W C Su; Z H You; Y Iwamoto; X Y Fu
Journal:  Science       Date:  1996-05-03       Impact factor: 47.728

10.  STAT1 mediates the increased apoptosis and reduced chondrocyte proliferation in mice overexpressing FGF2.

Authors:  M Sahni; R Raz; J D Coffin; D Levy; C Basilico
Journal:  Development       Date:  2001-06       Impact factor: 6.868

View more
  15 in total

Review 1.  Sixteen years and counting: the current understanding of fibroblast growth factor receptor 3 (FGFR3) signaling in skeletal dysplasias.

Authors:  Silvie Foldynova-Trantirkova; William R Wilcox; Pavel Krejci
Journal:  Hum Mutat       Date:  2011-11-16       Impact factor: 4.878

2.  Interferon-γ biphasically regulates angiotensinogen expression via a JAK-STAT pathway and suppressor of cytokine signaling 1 (SOCS1) in renal proximal tubular cells.

Authors:  Ryousuke Satou; Kayoko Miyata; Romer A Gonzalez-Villalobos; Julie R Ingelfinger; L Gabriel Navar; Hiroyuki Kobori
Journal:  FASEB J       Date:  2012-02-01       Impact factor: 5.191

3.  Label-free protein profiling of adipose-derived human stem cells under hyperosmotic treatment.

Authors:  Elizabeth S Oswald; Lewis M Brown; J Chloë Bulinski; Clark T Hung
Journal:  J Proteome Res       Date:  2011-06-14       Impact factor: 4.466

4.  Platelet-derived growth factor mediates interleukin-13-induced collagen I production in mouse airway fibroblasts.

Authors:  Jiamei Lu; Yanting Zhu; Wei Feng; Yilin Pan; Shaojun Li; Dong Han; Lu Liu; Xinming Xie; Guizuo Wang; Manxiang Li
Journal:  J Biosci       Date:  2014-09       Impact factor: 1.826

5.  Phenotype profile of a genetic mouse model for Muenke syndrome.

Authors:  Hyun-Duck Nah; Eiki Koyama; Nneamaka B Agochukwu; Scott P Bartlett; Maximilian Muenke
Journal:  Childs Nerv Syst       Date:  2012-08-08       Impact factor: 1.475

6.  A registry of achondroplasia: a 6-year experience from the Czechia and Slovak Republic.

Authors:  Martin Pesl; Hana Verescakova; Linda Skutkova; Jana Strenkova; Pavel Krejci
Journal:  Orphanet J Rare Dis       Date:  2022-06-16       Impact factor: 4.303

7.  STAT1 is Constitutively Activated in the T/C28a2 Immortalized Juvenile Human Chondrocyte Line and Stimulated by IL-6 Plus Soluble IL-6R.

Authors:  Evan C Meszaros; Charles J Malemud
Journal:  J Clin Cell Immunol       Date:  2015-04

Review 8.  SOCS proteins in regulation of receptor tyrosine kinase signaling.

Authors:  Julhash U Kazi; Nuzhat N Kabir; Amilcar Flores-Morales; Lars Rönnstrand
Journal:  Cell Mol Life Sci       Date:  2014-04-05       Impact factor: 9.261

9.  FGF-1/-3/FGFR4 signaling in cancer-associated fibroblasts promotes tumor progression in colon cancer through Erk and MMP-7.

Authors:  Yu-Pan Bai; Kun Shang; Huan Chen; Fei Ding; Zhen Wang; Chen Liang; Ye Xu; Meng-Hong Sun; Ying-Yi Li
Journal:  Cancer Sci       Date:  2015-09-04       Impact factor: 6.716

Review 10.  Role of suppressors of cytokine signaling 3 in bone inflammatory responses.

Authors:  Anqi Gao; Thomas E Van Dyke
Journal:  Front Immunol       Date:  2014-01-10       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.